Effect of intra-articular injection of mesenchymal stem cells in cartilage repair in experimental animals  by Kamel, Nadia Salah et al.
The Egyptian Rheumatologist (2014) 36, 179–186HO ST E D  BY
Egyptian Society of Rheumatic Diseases
The Egyptian Rheumatologist
www.rheumatology.eg.net
www.elsevier.com/locate/ejrORIGINAL ARTICLEEﬀect of intra-articular injection of mesenchymal
stem cells in cartilage repair in experimental
animals* Corresponding author. Tel.: +20 226223833.
E-mail address: irene_raouf@yahoo.com (I.R. Amin).
Peer review under responsibility of Egyptian Society of Rheumatic
Diseases.
http://dx.doi.org/10.1016/j.ejr.2014.03.001
1110-1164  2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Rheumatic Diseases.
Open access under CC BY-NC-ND license.
Open access under CC BY-NC-ND license.Nadia Salah Kamel a, Mona Mahmoud Arafa a, Amr Nadim d,
Hnaa Amer b, Irene Raouf Amin a,*, Naglaa Samir c, Amina Salem aa Department of Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, Ain Shams University, Egypt
b Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Egypt
c Department of Pathology, Faculty of Medicine, Ain Shams University, Egypt
d Department of Obstetrics and Gynecology, Faculty of Medicine, Ain Shams University, EgyptReceived 10 February 2014; accepted 8 March 2014
Available online 18 April 2014KEYWORDS
Intra articular injection;
Mesenchymal stem cells
(MSCs);
Cartilage repair;
Osteoarthritis;
Experimental animalsAbstract Osteoarthritis (OA) is characterized by degeneration of the articular cartilage and,
ultimately, joint destruction. Human umbilical cord blood (hUCB) may prove to be a new source
of mesenchymal stem cells (MSCs) for cellular therapeutics used for cartilage repair.
Aim of the work: This study was carried out over a nine-month period of time, to study the effect
of intra-articular injection of hUCB MSCs in cartilage repair by histopathological and ultra
structural assessment.
Materials and methods: We conducted our study on 20 adult rats, which were subjected to the
induction of cartilaginous defect in both knee joints. This was followed by injection of MSCs
suspended in Hyaluronic acid solution in the right knee of each rat while the left knee served as
a control. Histopathological and electron microscopic studies were performed.
Results: The present study revealed: In the injected knees; In 73% of the cases, the tissue was
typical of ﬁbrohyaline cartilage and appeared more cellular than ﬁbrous. In 27% of the cases the
repaired tissue appeared more ﬁbrous than hyaline. In the control knees; the newly formed tissue
was an undifferentiated connective tissue and the cells were covered with a thin layer of ﬁbrous
tissue. The electron microscopic pictures of the injected knees showed mitotic chondrocyte activity.
The pictures indicated a repaired ﬁbrohyaline cartilage.
Conclusion: We can conclude that the intra-articular injection of hUCB MSCs is an effective
method for cartilage repair in rats. This makes it a very promising tool for the treatment of patients
with OA.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Rheumatic Diseases.
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Osteoarthritis (OA) is a degenerative joint disease that is char-
acterized by erosion of the articular cartilage, growth of bone
at the margins i.e., osteophytes, subchondral sclerosis and a
range of biochemical and morphologic alterations of the syno-
vial membrane and joint capsule [1]. The primary tissue
affected is the thin rim of hyaline articular cartilage interposed
between the two articulating bones [2].
In early OA, the articular cartilage surface becomes
irregular, and superﬁcial clefts within the tissue become
apparent. As the condition worsens, the clefts deepen, surface
irregularities increase and the articular cartilage eventually
ulcerates, exposing the underlying bone [3]. Chondrocytes in
areas surrounding an injured zone are unable to migrate,
proliferate, repopulate, regenerate or repair tissue with similar
structure, function, and biomechanical properties of normal
hyaline cartilage [4].
The burden of OA is exacerbated by the inadequacies of
current therapies. Nonpharmacologic and pharmacologic
treatments are used for early and moderately early cases of
OA [5].
Mesenchymal stem cells (MSCs), which have the ability to
differentiate into cells of the chondrogenic lineage, are very
promising candidates to develop new cell-based articular carti-
lage repair strategies; this strategy entails the use of MSCs as
trophic producers of bioactive factors to initiate endogenous
regenerative activities in the OA joint [6]. Autologous bone
marrow (BM) represents the main source of MSCs for both
experimental and clinical studies; however as the number of
MSCs and their differentiation capacity decline with age, their
therapeutic potential might be diminished as well [7]. As sev-
eral ethical and practical issues arise from the use of BM
and fetal stem cells, umbilical cord blood (UCB) has turned
out to be an excellent alternative source of MSCs for clini-
cal-scale allogeneic transplantation [8].
It was postulated that hyaluronic acid might facilitate the
migration and adherence of MSCs to the defect, which might
explain the occurrence of partial healing at 6 weeks in animals
that were treated with hyaluronic acid alone. The repaired
tissue in animals treated with hyaluronic acid alone was of
inferior quality and was shown to deteriorate further after
12 weeks, so the combination between MSCs and hyaluronic
acid will result in synergistic effect [9].
Aim of the Work: This study was carried out over a nine-
month period of time, to study the effect of intra-articular
injection of human umbilical cord blood (hUCB) mesenchy-
mal stem cells (MSCs) in cartilage repair by histopathological
and ultra structural assessment.2. Materials and methods
The study was carried out on twenty albino rats of Wistar
strain (adult males) during a nine-month period of time. They
were brought from the medical research center, faculty of
medicine, animal house of Ain Shams University. This study
was approved by the local ethical committee.
The animals were maintained under conditions of
controlled humidity, they were fed with commercial rat pellets
and water. The animal house staff detected the age and weightof the animals and supervised their feeding. All animals were
healthy and had no joint problems.
2.1. All animals were subjected to the following
Induction of cartilaginous defect in both knee joints by
scratching the cartilage using a sterile needle [10,11]. In
maximal ﬂexion, longitudinal and diagonal grooves were made
on the weight-bearing parts of femoral condyles without
damaging the subchondral bone. The latter was checked by
histology in 2 of the rats which were sacriﬁced; one of them
after 1 week and the other after 4 weeks from the scratching
which was done in the beginning of the experiment in order
to ensure development of osteoarthritis (OA).
2.2. Preparation of MSCs from human umbilical cord blood
(UCB)
2.2.1. Collection of UCB
Umbilical cord blood was obtained from the labor room of
Obstetrics and Gynecology Department, Faculty of Medicine,
Ain Shams University after written consent from the mothers.
4 UCB samples from full-term deliveries were collected
from the unborn placenta using complete aseptic technique
in sterile 15 ml Falcon tubes (Nunclon, Germany) containing
2 ml of acid citrate dextrose (ACD) anticoagulant (Lonza,
Switzerland). The samples were stored at 22 ± 4 C before
processing [12]. Isolation and culture of MSCs were carried
out in the medical research center, Faculty of Medicine, Ain
Shams University as follows.
2.2.2. Isolation of mononuclear cells (MNCs)
Under complete asepsis each UCB sample was diluted 1:1 with
phosphate-buffered saline (PBS) (lonza) and was carefully
loaded onto Ficoll–Hypaque solution 2:1 ratio. After density
gradient centrifugation at 2000 rpm for 30 min at room
temperature, MNCs were removed from the interphase (the
Buffy coat) and were washed three times with PBS; each time
were centrifuged at 1500 rpm for 5 min, a clear cell pallet was
formed in the bottom of the tube [13].
2.2.3. Culture of mesenchymal stem cells
The cells were cultured in complete culture medium;
Dulbecco’s modiﬁed Eagle’s medium (DMEM) (Lonza, Swit-
zerland) containing 12% fetal calf serum, 1% antibiotics –
antimycotic; 100 units/ml of penicillin, 100 lg/ml of
streptomycin and 250 lg/ml Amphotericin B. Cells were
placed in 25 ml Falkon ﬂasks (Nunclon, Germany). The ﬂasks
were incubated at 37 C in 5% CO2 (NuAire, USA).
On the ﬁfth day of culture, non-adherent cells were
discarded and adherent cells were examined microscopically
for morphological evaluation of spindle shaped cells. The com-
plete medium was changed and the ﬂasks were reincubated.
Flasks were examined every other day for MSCs (spindle
shaped, ﬁbroblast like cells).
After 2 weeks of culture, the adherent cells were almost
conﬂuent. Adherent cells were harvested using 0.25% trypsin
for 5 min at 37 C, 5 ml of medium was added to deactivate
it. Cells were then counted with a haemocytometer. Cells were
then collected in a 15 ml Falcon tube and centrifuged at
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sediment washed twice with PBS, and then centrifuged
1500 rpm for 5 min [14].
2.2.4. Preparing MSCs for injection
After isolating MSCs we suspended them in 2 ml of
Hyaluronic acid solution (Hyalgan, Sanoﬁ Aventis, USA)
at a density of 1.2–1.5 · 106 cells/ml.
2.3. Injection of animals
Injection of MSCs suspended in Hyaluronic acid solution was
done in the right knee of each rat after sterilization with
Betadine solution. The left knee served as a control [15].
2.4. Preparation of histological sections of the knee joint
Animals were sacriﬁced by intraperitoneal injection of a lethal
dose of thiopental (50 mg/kg) after 6 weeks of injection and
knee joints were removed. Histopathological study was done
to examine chondrogenic regenerative changes of the animal
articular cartilage after injection [16].
The total knee joints were removed and ﬁxed for 4 days in
10% neutral formalin, decalciﬁed by 5% formic acid in
distilled water. The decalcifying solution was renewed every
48 h until softening of the tissues. The decalciﬁed specimens
were washed and dehydrated in ascending grades of alcohol,
cleared in xylene and embedded in parafﬁn. From each
parafﬁn block, longitudinal sections (5 lm) were cut and
stained with hematoxylin & eosin and Masson’s trichrome
(for detection of collagen ﬁbers).
2.5. Experimental assessment
Our experimental assessment was done to detect the develop-
ment of OA in the knees of the studied rats and this depended
upon subjective observational parameters as limping and/or
aggressive behavior denoting pain.
2.6. Histopathological assessment
Each stained section was examined with a light microscope to
assess the following criteria for cartilage repair: (1) Tissue
morphology (2) Surface architecture (3) Clustering of chon-
drocytes (4) Thickening of repaired cartilage (5) Synovial cell
proliferation and inﬂammation.
The control slides were examined to assess the following
criteria for osteoarthritic changes: (1) Surface irregularities
(2) Organization and hypertrophy of chondrocytes and (3)
The degree of proliferation and inﬂammation of synovial cells.
2.7. Preparation for electron microscopic (EM) study
The right (injected) knee joint of one of the knees was opened
anteriorly by cutting through the ligamentum patellae. The
articular cartilage surface was immediately washed with saline.
Washing continued while the knee was disarticulated. The soft
tissue surrounding the femur was reﬂected proximally and thelimb amputated at the middle of femoral shaft. Specimen thus
consisted of the distal half of the femur.
2.8. EM preparation of the sample
First, the specimen was immersed in freshly prepared glutaral-
dehyde, buffered with 0.1 M sodium cocodylate at pH 7.3.The
specimen was then left for 4 h at a temperature of four degrees
centigrade. The specimen was then washed for 2 h in the three
changes of the same buffer. Then, it was post-ﬁxed in 1%
osmium tetroxide for two hours in the refrigerator. The speci-
men was then washed in three changes of the same buffer for
half an hour in each change. After post-ﬁxation, dehydration
of the specimen was carried out through ascending grades of
ethanol alcohol at four degrees centigrade as follows: 30 min
in each of the following concentrations of ethanol alcohol,
50%, 70%, 80% and 95%. Then, we used three changes alco-
hol for 30 min. At room temperature, the specimen was treated
with three changes of propylene oxide over a period of one and
a half hours. The specimen was impregnated in a mixture of
equal parts of epoxy resin mixture and propylene oxide for
8 h. Finally, specimen was embedded in pure resin and was left
for 48 h in an oven at 60 C for polymerization of the resin.
Section cutting was done on an LKB ultramicrotome. Ultra
thin sections were obtained and picked up on coated copper
grids. The ultrathin sections were stained with urenyl acetate
for 30 min, and then followed by lead citrate for 15 min. The
stained ultrathin sections were examined under transmission
electron microscope; Sumy electron optics (TEM-100 SEO)
Ukraine, at 60 kV accelerating voltage.
Electron microscopic study was done to visualize mitotic
pictures (newly formed chondrocytes and chondroblasts), also
to assess the collagen ﬁbers and the matrix arrangement.
Statistical analysis: Data collected were presented in the
form of numbers and percentages.
3. Results
This study was carried out on twenty albino rats of Wistar
strain (adult males). Their age ranged from 6 to 12 months
and their weight ranged from 180 to 220 g. All the animals were
subjected to induction of cartilaginous defect in both knee
joints by scratching the cartilage using a sterile needle in order
to develop OA. Experimental assessment, in the form of obser-
vation of limping and/or aggressive behavior denoting pain,
revealed development of OA in all the studied rats. The 2 rats
which were sacriﬁced after 1 and 4 weeks from the scratching
maneuver showed evidence of development of OA in the form
of ﬁbrillation of the surface, the chondrocytes were smaller and
lying in parallel longitudinal rows, the synovial cells showed
mild proliferation and mild inﬁltration by inﬂammatory cells.
After induction of OA by scratching, one of the animals
died before being injected. After 6 weeks of scratching; injec-
tion of MSCs suspended in hyaluronic acid solution was done
in the right knee of 17 rats and the left knee served as a control.
After injection none of the animals was limping or aggressive.
The animals were killed after 6 weeks of injection and knee
joints were removed. Two of the animal samples were used in
the electron microscopic study and the rest of the 15 animal
samples were used for the histopathological assessment.
Figure 1 (a) Control knees: Granulation tissue at the site of
articular injury (H&E ·400).
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In the control group (left knees) (Table 1): the area of the
defect was partially ﬁlled with a ﬁbrovascular granulation
tissue, which united the wound edges (Fig. 1a). The newly
formed tissue was composed of undifferentiated connective
tissue cells covered with a thin layer of ﬁbrous tissue. It was
grossly distinguishable from the surrounding normal tissue.
Cartilaginous sequestra surrounded by organized ﬁbrous tissue
were seen (Fig. 1b). All the control knees did not show any
signs of cartilage repair.
In the injected group (right knees) (Table 2): no signs of OA
such as osteophytes, cysts formation, cartilage erosion or syno-
vial proliferation were observed in any of the knees; ﬁbrocar-
tilaginous mass was detected at the region of the defect by
Masson’s trichrome stain in 4 treated knees (27%). The tissue
appeared more ﬁbrous than hyaline. The surface became mod-
erately ﬁbrillated, the chondrocytes were smaller and lying in
parallel longitudinal rows, the subjacent matrix was densely
ﬁbrous and the synovial cells showed mild proliferation and
mild inﬁltration by inﬂammatory cells (Fig. 2). In the
remaining 11 treated knees (73%): the tissue was typical of
ﬁbro-hyaline cartilage and appeared more cellular than
ﬁbrous. These ﬁndings were conﬁrmed by Masson’s trichrome
stain that demonstrated pink nuclei subjacent to the pale blue
staining matrix and ﬁne ﬁbrous tissue network showing intense
metachromasia that divided the chondrocytes into clusters
(Figs. 3a–c).
3.2. Electron microscopic ﬁndings
As regards the EM study of the MSC-injected knees; it showed
a repaired ﬁbro-hyaline cartilage demonstrated by many
chondrocytes and chondroblasts. The chondrocytes had
centrally positioned nuclei surrounded by a rich rough
endoplasmic reticulum (rER) and numerous mitochondria.
The chondrocytes also showed chondrocyte mitotic activity.
The matrix displayed ﬁne collagen ﬁbrils (Fig. 4a). In some
areas thick bundles of collagen ﬁbrils, which were sectionedTable 1 Histopathological ﬁndings of the control knees (Lt. side).
No Joint surface Chondrocytes
Irregularity Disorganization
1 2 1
2 1 1
3 2 2
4 1 1
5 2 1
6 1 1
7 2 2
8 1 2
9 1 1
10 1 1
11 1 1
12 2 2
13 1 1
14 2 2
15 2 2
Normal = 0, Mild = 1, Moderate = 2, Severe = 3.both transversely and longitudinally, were seen. Individual
ﬁbrils displayed alternating transverse dark and light banding
along their length (Fig. 4b). The pictures indicated a repaired
ﬁbro-hyaline cartilage.
4. Discussion
Osteoarthritis is a major cause of disability in the elderly; the
prevalence of this disease is expected to increase dramatically
over the next 20 years with aged population [17,18]. The
burden of OA is exacerbated by the inadequacies of current
therapies. Non-pharmacologic and pharmacologic treatments
are used for early and moderately early cases of OA, but pro-
tection of articular cartilage has so far not been convincinglySynovial cells
Hypertrophy Proliferation Inﬂammation
1 2 2
1 2 2
1 1 1
1 2 2
1 2 2
1 1 1
1 2 2
2 2 2
1 1 1
1 1 1
1 1 1
1 2 2
1 1 1
2 2 2
2 2 2
Figure 1 (b) Control knees: Organization and formation of
cartilaginous sequestra surrounded by disorganized ﬁbrous tissue
(H&E ·200).
Figure 2 Injected Knee: Chondroﬁcation of old granulation
tissue (arrow) with ﬁbrillated surface (star) (H&E ·200).
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symptoms cannot be controlled and the disease progresses [20].
Whether arthroscopic lavage and/or debridement can provide
symptomatic relief is unclear [21]. Consequently, patients with
severe OA are currently excluded from these treatments [22].
Rats as animal models have a short life span, are available,
cheap and well adapted to our climate, these characters made
them ideal for this study. Animals used in this study were adult
rats because the cartilage of adult animals is resistant to repair
than in immature animals and therefore more similar to adult
human subjects [23]. We excluded females because they usually
get pregnant which may disturb the study by additional factors
out of the scope of our study.
Scratching the cartilage has the advantages that it is easy to
perform and it induces partial thickness cartilage defect that
does not reach the subchondral bone, so there is no involve-
ment of the vasculature. Consequently, progenitor cells in
blood and marrow cannot enter the damaged region toTable 2 Histopathological ﬁndings of the mesenchymal stem cells (
No Tissue
morphology
Surface architecture
(irregularity)
Chondrocyte
clustering
C
th
1 HF 2 2 2
2 F 1 2 1
3 HF 2 2 2
4 HF 2 2 2
5 HF 2 2 2
6 HF 2 2 2
7 F 1 2 1
8 HF 2 2 2
9 F 1 2 1
10 HF 1 2 1
11 HF 1 2 1
12 HF 1 2 1
13 F 1 2 1
14 HF 2 2 1
15 HF 2 2 2
Normal = 0, Mild = 1, Moderate = 2, Severe = 3. Fibro cartilage = F,inﬂuence or contribute to the reparative process to ensure that
any chondral repair is entirely from the injected cells [10].
Since most OA models use knee joints, an important con-
sideration in the use of these models is the load-bearing pattern
of the species being used [24]. So we did not prevent the animal
from weight bearing after induction of the cartilage defect, to
eliminate the rest factor that may share in the healing process
and we started treatment after 6 weeks of scratching to ensure
that the OA is well established. On the other hand, Yanai et al.
[25] established an animal model of large full-thickness
articular cartilage defects in the knee of rabbits using a hinged
ﬁxator and considered joint distraction to be favorable for the
regeneration.
Human umbilical cord blood (hUCB) MSCs have many
advantages because of the immaturity of newborn cells com-
pared with adult cells also could be more convenient for cell
transplantation and be a more economical source of MSCs,
than bone marrow MSC. Furthermore, hUCB provides no
ethical problems for basic studies and clinical applications
[26]. The study of Erices et al. [27] provided strong evidenceMSCs) injected knees (Rt. Side).
artilage
ickening
Synovial cells Dose of injected
cells (million cell)
Proliferation Inﬂammation
1 1 1
2 2 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 5
1 1 5
1 1 5
1 1 5
1 1 3
1 1 3
2 2 3
1 1 3
1 1 3
Hyaline-Fibrocartilage = HF.
Figure 3 (c) Injected Knee: Hypercellular hyaline-like cartilage
in which the ﬁbrous network divides the chondrocytes into clusters
(Masson’s trichrom ·400).
Figure 3 (b) Injected Knee: Mature chondrocyte with subjacent
ﬁbrohyaline matrix (H&E ·400).
Figure 4 (a) Chondrocytes surrounded by ﬁne collagen ﬁbrils
(TEM ·3000).
Figure 3 (a) Injected Knee: Fibrohyaline cartilage covering the
articular surface (H&E ·200).
Figure 4 (b) Bundles of collagen ﬁbrils (TEM ·15,000).
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hUCB. Rosada et al. [28] has reported that cord blood
multilineage cells are slower to establish in culture, have a
lower precursor frequency and a lower level of bone antigen
expression, and lack constitutive expression of neural antigens
when compared with bone marrow, suggesting a more primi-
tive population. The hUCB is easy to obtain and to store,
and its use for hematopoietic stem cell transplantation does
not require a close human leucocyte antigen match as reported
by Gluckman [29].
Human UCB stem cells are xenograft cells. Rat UCB is dif-
ﬁcult to obtain and the available quantity of rat UCB is very
limited; however, hUCB is easy to obtain and is plentiful. In
our experiment, we expected to evaluate only the possibility
of UCB stem cells differentiated into chondrocytes in vivo.
So, we used hUCB in the rat model. Umbilical cord blood
may prove to be a new source of cells for cellular therapeutics
for stromal, bone, and potentially, cartilage repair. Also it is a
very promising source in Egypt because of the high birth rate.
For all the above-mentioned reasons, cord blood MSCs were
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cartilage repair.
Due to the speciﬁc structure and functions of placenta,
human extra-embryonic MSCs, including MSCs derived from
the UCB represent stem cell types, which combine some
properties of pluripotent embryonic stem cells with other prop-
erties of multipotent MSCs. They have immunoprivileged
characteristics, posses a broader plasticity, and proliferate
faster than adult MSCs [30].
The hUCB MSCs were delivered in this study by intra-
articular injection, there are 2 different approaches to this.
One is to implant cells directly with or without a suitable
matrix or scaffold seeded with chondroprogenitor cells and sig-
naling substances as in the study of Jackson and Simon [31].
The alternative is to differentiate stem cells in vitro and
implant a mature construct. The ability of stem cells to differ-
entiate and adhere to scaffolds such as matrices of hyaluronan
derivatives and gelatin-based resorbable sponge matrices has
been investigated and proven by Solchaga et al. [32], and
Ponticello et al. [33] respectively.
Most studies presume that scaffolds are required for the
regeneration of cartilage. It is ventured that loads and ﬂuid
movements would simply prevent cells from thriving where
they are needed. However Barry [34] has shown that MSCs
can survive and thrive without a scaffold and injected stem
cells have been recovered in viable form in a goat knee with
simulated arthritis.
In the present study hUCB MSCs were delivered by intra-
articular injection in a suspension of hyaluronic acid (HA)
solution without the use of a solid biomatrix 6 weeks after
scratching the cartilage. Lee et al. [9] postulated that HA might
facilitate the migration and adherence of MSCs to the defect.
Our choice of experimental animals to be rats, limited our
ability to experimental assessment. It was limited to subjective
observational parameters such as limping or aggressive behav-
ior denoting pain, so we chose the histopathological assess-
ment and ultrastructural study that were based upon
histological objectives. Samples were stained with hematoxylin
& eosin and Masson’s trichrome.
In the present study, the repair of lesions was a variable mix-
ture of ﬁbrous tissue, ﬁbrocartilage and hyaline-like cartilage.
At 6 weeks at the control group; the area of the defect was ﬁlled
with a ﬁbrovascular granulation tissue, the newly formed tissue
was an undifferentiated connective tissue covered with a thin
layer of ﬁbrous tissue. Cartilaginous sequestra surrounded by
organized ﬁbrous tissue were seen. All control knees did not
show any signs of repair (differentiated cartilage) denoted that
there is no systemic parenteral trafﬁcking through systemic cir-
culation from the injected right knee to the other left knee.
These ﬁndings coincide with those reported by Yanai et al.
[25], Bos et al. [35], and Lee et al. [9]. However in this study
the tissue appeared more ﬁbrous than cartilaginous.
At the injected group; no signs of OA such as osteophytes,
cysts formation, cartilage erosion or synovial proliferation,
were observed in any of the knees these ﬁndings match with
that of Lee et al. [9].
After 6 weeks of injection ﬁbrocartilaginous mass was
detected in 27% of cases. The tissue appeared more ﬁbrous
than cartilaginous and the surface layers and the cells were
more typically ﬁbrocartilaginous than hyaline. The surface
became moderately ﬁbrillated, the chondrocytes are smaller
and lying in parallel longitudinal rows, the subjacent matrixwas densely ﬁbrous and the synovial cells showed mild prolif-
eration and mild inﬁltration by inﬂammatory cells. In 73% of
cases; the tissue appeared more cellular than ﬁbrous. The thin
ﬁbrillated surface and the cells were typical of ﬁbro-hyaline
cartilage; these ﬁndings match with those of Yanai et al. [25],
Yan and Yu [36], and Lee et al. [9].
Regarding the EM study; it showed a repaired ﬁbrohyaline
cartilage demonstrated by many chondrocytes and chondro-
blasts. The pictures indicated a repaired ﬁbrohyaline cartilage.
A recent study conducted by Nam and his colleagues [37],
showed a superior role of injecting autologous bone marrow
derived mesenchymal stem cells (BM-MSCs) to hUCB MSCs.
This study demonstrated hyaline-like cartilage regeneration in
the knees of goats receiving BM-MSCs after two full-thickness
chondral 5 mm diameter defects were created. They suggested
that supplementing intra-articular injections of BM-MSCs fol-
lowing bone marrow stimulation (BMS) knee surgery provides
superior cartilage repair outcomes.
We can conclude from these results that the intra-articular
injection of hUCB MSCs is an effective method for cartilage
repair in rats. This makes it a very promising tool for the treat-
ment of patients with OA.Conﬂict of interest
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